We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Innovent Bio’s Cancer Drug Shows Promise in Late-Stage Trial
Innovent Bio’s Cancer Drug Shows Promise in Late-Stage Trial
Innovent Biologics said its investigational gastric cancer drug sintilimab plus chemotherapy delivered promising results in a phase 3 trial as a first-line treatment.